With over 8 years of experience, Cylaos is a leading distributor approved by international brands of reference (polymer) 3D printers, and masters all the key related services for the integration of additive manufacturing solutions (audit and consultancy, training and maintenance).
The business was initially focused on high added-value products for professionals in the industrial sector (automotive, military, jewellery, cosmetics, etc.), before diversifying into the medical (hospitals, clinics, orthotists, orthopaedists, prosthetists, etc.) and dental sectors.
In 2024, the group will employ around twenty people in France (including Nantes, Paris and Lyon), generating sales of €6m. The Group has been growing strongly since 2020, with an average annual growth rate of over 30%.
The main thrusts of Cylaos' future development will be:
- Accentuating its leading position in the brands it markets;
- Growth in certain verticals (dental and medical) with innovative and disruptive solutions;
- Expanding the product and service offering of brands already in the catalogue;
- The spread of additive manufacturing as a key component of Industry 4.0;
The company wants to maintain a strong pace of organic growth while consolidating its profitability. As Cylaos has reached a key stage in its development, the company has opened up its capital to Capitem 4, which is taking a minority stake.
PARTIES INVOLVED IN THE TRANSACTION
Company: CYLAOS (Jean-Michel et Olivier LUCAS)
Financial investor: Capitem Partenaires (Stéphane Grès, Philippe Pruvot, Damien Gassies, Leatitia Grosgogeat et Nicolas Schlitz)
Capitem legal advisor: A2 Avocats (Anaïs Lecarpentier)
Financial due diligence: AUROFI (Grégory Rojkoff, Grégory Sève, Hugo Portella)
